Literature DB >> 14603055

Expression of intercellular adhesion molecule (ICAM)-1 in adenoid cystic carcinoma of the head and neck.

Akiko Shirai1, Mitsuru Furukawa, Tomokazu Yoshizaki.   

Abstract

OBJECTIVES/HYPOTHESIS: Adenoid cystic carcinoma of the head and neck (ACCHN) is characterized by late recurrence and frequent distant metastasis. Tumor attack by cytotoxic T lymphocytes and macrophages is mediated by the interaction of leukocyte function-associated antigen (LFA)-1 on lymphocytes with intercellular adhesion molecule (ICAM)-1 on the tumor surface. Thus, the reduced expression of ICAM-1 on tumor cells could contribute to their escape from host immune surveillance. To investigate the relationship between the clinical features of ACCHN and host immune surveillance, the expression of ICAM-1 and infiltration of T/natural killer (NK) cells and macrophages were immunohistochemically examined. STUDY
DESIGN: Retrospective analysis of immunohistochemical tumor characteristics and clinical outcome.
METHODS: Immunohistochemical study of ICAM-1, T/NK cells, and macrophages was performed on paraffin sections of 42 patients with ACCHN. The expression of T/NK cells and macrophages was represented by T-cell-restricted antigen (TIA)-1 and CD68 expression, respectively. The expression of these molecules and clinical features were analyzed.
RESULTS: Of 42 ACCHN cases, 15, 9, and 15 patients were classified as ICAM-1 high, TIA-1 high, and CD68 high, respectively. The TIA-1 expression scores in ICAM-1-low patients were significantly lower than those in ICAM-1-high patients (1.3 +/- 3.7 vs. 8.3 +/- 12.7, P =.0031). The CD68 expression scores in ICAM-1-low patients were also significantly lower than those in ICAM-1-high patients (9.6 +/- 9.6 vs. 21.1 +/- 17.6, P =.0047). Moreover, ICAM-1-high patients had a significantly better disease-free survival rate (P =.043).
CONCLUSIONS: Reduced expression of ICAM-1 may promote immune evasion and metastasis, resulting in poor prognosis in ACCHN.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14603055     DOI: 10.1097/00005537-200311000-00019

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  9 in total

1.  CD54 expression is predictive for lymphatic spread in human gastric carcinoma.

Authors:  Masakazu Yashiro; Takeshi Sunami; Kosei Hirakawa
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

2.  ICAM gene cluster SNPs and prostate cancer risk in African Americans.

Authors:  Hankui Chen; Wenndy Hernandez; Mark D Shriver; Chiledum A Ahaghotu; Rick A Kittles
Journal:  Hum Genet       Date:  2006-05-30       Impact factor: 4.132

Review 3.  Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis.

Authors:  Zhiwei Hu; Samira A Brooks; Valérian Dormoy; Chia-Wen Hsu; Hsue-Yin Hsu; Liang-Tzung Lin; Thierry Massfelder; W Kimryn Rathmell; Menghang Xia; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Dustin G Brown; Kalan R Prudhomme; Annamaria Colacci; Roslida A Hamid; Chiara Mondello; Jayadev Raju; Elizabeth P Ryan; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Hosni K Salem; Leroy Lowe; Lasse Jensen; William H Bisson; Nicole Kleinstreuer
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

Review 4.  How patients with an intact immune system develop head and neck cancer.

Authors:  Sarah Greene; Priya Patel; Clint T Allen
Journal:  Oral Oncol       Date:  2019-03-18       Impact factor: 5.337

5.  Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer.

Authors:  Paul J Mills; Sonia Ancoli-Israel; Barbara Parker; Loki Natarajan; Suzi Hong; Shamini Jain; Georgia R Sadler; Roland von Känel
Journal:  Brain Behav Immun       Date:  2007-08-15       Impact factor: 7.217

6.  Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1.

Authors:  Ryo Ueda; Gary Kohanbash; Kotaro Sasaki; Mitsugu Fujita; Xinmei Zhu; Edward R Kastenhuber; Heather A McDonald; Douglas M Potter; Ronald L Hamilton; Michael T Lotze; Saleem A Khan; Robert W Sobol; Hideho Okada
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-11       Impact factor: 11.205

7.  Genetic and epigenetic changes in human prostate cancer.

Authors:  S Koochekpour
Journal:  Iran Red Crescent Med J       Date:  2011-02-01       Impact factor: 0.611

Review 8.  Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review.

Authors:  Pierre Loap; Barbara Vischioni; Maria Bonora; Rossana Ingargiola; Sara Ronchi; Viviana Vitolo; Amelia Barcellini; Lucia Goanta; Ludovic De Marzi; Remi Dendale; Roberto Pacelli; Laura Locati; Valentin Calugaru; Hamid Mammar; Stefano Cavalieri; Youlia Kirova; Ester Orlandi
Journal:  Front Oncol       Date:  2021-11-30       Impact factor: 6.244

9.  Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance.

Authors:  Jian Sun; Yixi Luo; Zhen Tian; Liang Gu; Shu Chi Xia; Youcheng Yu
Journal:  BMC Cancer       Date:  2012-10-30       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.